CorMedix
CRMD
79 hedge funds and large institutions have $55M invested in CorMedix in 2021 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 24 increasing their positions, 21 reducing their positions, and 10 closing their positions.
61% more call options, than puts
Call options by funds: $938K | Put options by funds: $581K
14% more repeat investments, than reductions
Existing positions increased: 24 | Existing positions reduced: 21
10% more first-time investments, than exits
New positions opened: 11 | Existing positions closed: 10
1.14% more ownership
Funds ownership: 29.86% → 31% (+1.1%)
0% more funds holding
Funds holding: 79 → 79 (0)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
29% less capital invested
Capital invested by funds: $78M → $55M (-$23M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Nomura Holdings
Tokyo,
Japan
|
+$2.54M |
| 2 |
Renaissance Technologies
New York
|
+$687K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$412K |
| 4 |
State Street
Boston,
Massachusetts
|
+$384K |
| 5 |
Morgan Stanley
New York
|
+$373K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
OFG
Oxford Financial Group
Carmel,
Indiana
|
-$418K |
| 2 |
Two Sigma Investments
New York
|
-$404K |
| 3 |
State Board of Administration of Florida Retirement System
Tallahassee,
Florida
|
-$335K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$263K |
| 5 |
Two Sigma Advisers
New York
|
-$258K |
CRMD Hedge Fund Activity: Q3 2021 in Review
79 of the 5,728 institutional investors tracked by Wall St. Rank reported a position in CorMedix (CRMD) for Q3 2021, worth a combined $55M — down 29% from $78M a quarter earlier.
Buyers outnumbered sellers: 11 funds opened new CRMD positions and 10 closed out — a net gain of 1 holder — while 24 added to existing stakes and 21 trimmed.
The largest buyer was Nomura Holdings, opening a new position worth an estimated $2.54M. The largest seller was Oxford Financial Group, exiting entirely with an estimated $418K sold.
- 79 institutional investors held CorMedix (CRMD) as of Q3 2021, unchanged from Q2 2021.
- Funds reported $55M of CorMedix stock for Q3 2021, down 29% quarter-over-quarter.
- 11 funds opened new CorMedix positions in Q3 2021 and 10 closed out, a net change of +1 holder.
- The largest CorMedix buyer in Q3 2021 was Nomura Holdings, an estimated $2.54M added.
- The largest CorMedix seller in Q3 2021 was Oxford Financial Group, an estimated $418K sold.
Based on aggregated 13F filings for Q3 2021.